Samsung Biologics Co.,Ltd.
207940
Kedudukan dalam Saham
#496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Harga Saham
$1,028.49
Modal Pasaran
$47.88B
Perubahan (1 hari)
-3.67%
Perubahan (1 tahun)
-18.37%
Negara
KR
Perdagangan Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
Sejarah pecahan saham untuk Samsung Biologics Co.,Ltd. (207940)
Saham Samsung Biologics Co.,Ltd. (simbol: 207940) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Oct 30, 2025.
Satu saham 207940 yang dibeli sebelum Oct 30, 2025 kini bersamaan dengan 0.650391 saham 207940.
Pecahan saham terkini berlaku pada Oct 30, 2025.
Satu saham 207940 yang dibeli sebelum Oct 30, 2025 kini bersamaan dengan 0.650391 saham 207940.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2025-10-30 | 650391:1000000 | x0.650391 | x0.650391 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
